PE20141723A1 - Metodo para monitoreo, diagnostico y/o pronostico de trastornos relacionados con hipoxia utilizando nfat5 - Google Patents

Metodo para monitoreo, diagnostico y/o pronostico de trastornos relacionados con hipoxia utilizando nfat5

Info

Publication number
PE20141723A1
PE20141723A1 PE2014000470A PE2014000470A PE20141723A1 PE 20141723 A1 PE20141723 A1 PE 20141723A1 PE 2014000470 A PE2014000470 A PE 2014000470A PE 2014000470 A PE2014000470 A PE 2014000470A PE 20141723 A1 PE20141723 A1 PE 20141723A1
Authority
PE
Peru
Prior art keywords
nfat5
monitoring
hypoxia
prognosing
diagnosing
Prior art date
Application number
PE2014000470A
Other languages
English (en)
Inventor
Munoz Carlos Ernesto Irarrazabal
Original Assignee
Univ Los Andes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48044247&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20141723(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Los Andes filed Critical Univ Los Andes
Publication of PE20141723A1 publication Critical patent/PE20141723A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7038—Hypoxia

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A UN METODO PARA EL MONITOREO, DIAGNOSTICO Y PRONOSTICO DE HIPOXIA RELACIONADO A TRANSTORNOS EN UN PACIENTE USANDO NFAT5, EN DONDE EL METODO COMPRENDE: a) PROPORCIONAR UNA MUESTRA DEL CUERPO, QUE ES SANGRE, ORINA, ENTRE OTROS; b) CONCENTRAR LOS FACTORES DE TRANSCRIPCION PRESENTES EN LA MUESTRA; Y c) DETECTAR Y CUANTIFICAR NFAT5 EN LA MUESTRA TRATADA.
PE2014000470A 2011-10-03 2012-10-03 Metodo para monitoreo, diagnostico y/o pronostico de trastornos relacionados con hipoxia utilizando nfat5 PE20141723A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161542446P 2011-10-03 2011-10-03

Publications (1)

Publication Number Publication Date
PE20141723A1 true PE20141723A1 (es) 2014-11-26

Family

ID=48044247

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2014000470A PE20141723A1 (es) 2011-10-03 2012-10-03 Metodo para monitoreo, diagnostico y/o pronostico de trastornos relacionados con hipoxia utilizando nfat5

Country Status (8)

Country Link
US (1) US9631237B2 (es)
EP (1) EP2764114A4 (es)
BR (1) BR112014007947A2 (es)
CL (1) CL2014000809A1 (es)
CO (1) CO7020868A2 (es)
HK (1) HK1200877A1 (es)
PE (1) PE20141723A1 (es)
WO (1) WO2013050950A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2877108T3 (es) * 2014-09-04 2021-11-16 Univ Johns Hopkins Activación de linfocitos infiltrantes de médula en condiciones hipóxicas alternantes con normóxicas
CA3142023A1 (en) * 2019-05-28 2020-12-03 Case Western Reserve University Compositions and methods for preserving dna methylation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158010A0 (en) 2003-09-18 2004-03-28 Hadasit Med Res Service Methods and kits for the detection of prion diseases
US20080039416A1 (en) * 2004-06-02 2008-02-14 Ho Steffan N Methods for Treating Disease by Modulating an Osmotic Stress Pathway
WO2007114449A1 (en) 2006-03-28 2007-10-11 Oncorex, Inc. Low-glucose-inducible or low-glucose-and-hypoxia-inducible genes, proteins, and uses thereof
EP2099933A4 (en) 2006-11-21 2010-03-24 Beth Israel Hospital HYPOXIA-ASSOCIATED GENES AND PROTEINS FOR THE TREATMENT AND DIAGNOSIS OF PREGNANCY-RELATED COMPLICATIONS
ES2480193T3 (es) 2008-07-18 2014-07-25 Hill's Pet Nutrition, Inc. Composiciones y métodos para tratar osteoartritis
JP2010187469A (ja) 2009-02-12 2010-08-26 Hitachi Consumer Marketing Inc 消費エネルギー積算値管理警報システム
WO2011057172A1 (en) 2009-11-06 2011-05-12 University Of Miami Podocyte specific assays and uses thereof

Also Published As

Publication number Publication date
US9631237B2 (en) 2017-04-25
EP2764114A2 (en) 2014-08-13
BR112014007947A2 (pt) 2017-04-18
US20140255947A1 (en) 2014-09-11
CL2014000809A1 (es) 2014-11-28
WO2013050950A3 (en) 2013-06-13
EP2764114A4 (en) 2015-05-06
CO7020868A2 (es) 2014-08-11
WO2013050950A2 (en) 2013-04-11
HK1200877A1 (en) 2015-08-14

Similar Documents

Publication Publication Date Title
MX2013000916A (es) Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales.
EA201590027A1 (ru) Способы детекции заболеваний или состояний
ES2570632T3 (es) Procedimiento de determinación del inhibidor de elastasa de leucocito in vitro del cáncer colorrectal
DOP2014000174A (es) Composición y método para el diagnóstico y el tratamiento de las enfermedades asociadas a la degeneración de las neuritas
CO6731117A2 (es) Metodos para diagnosticar y tratar desórdenes relacionados con la longitud axial del ojo
BR112014005947A2 (pt) sistema de monitoramento de uma cadeia de medida de um turborreator
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
EA201591742A1 (ru) Способ улучшения диагностики заболеваний с использованием измеряемых аналитов
BR112014009223A8 (pt) método para o diagnóstico da doença de niemann-pick
AR087363A1 (es) Uso del anticuerpo i-3859 para la deteccion y diagnostico de los canceres
GB201201766D0 (en) Method
UY35719A (es) Marcadores de riesgo para cardiovasculopatías en pacientes con nefropatía crónica
DK3161165T3 (da) Fremgangsmåde til diagnosticering af subklinisk og klinisk akut afstødning ved analyse af prædiktive gensæt, terapeutisk middel til anvendelse ved behandlingen og kits til at bestemme ekspressionen
PE20141723A1 (es) Metodo para monitoreo, diagnostico y/o pronostico de trastornos relacionados con hipoxia utilizando nfat5
BR112013002792A2 (pt) método e sistema para realizar operações em poços
GB201114909D0 (en) Biomarkers for lysosomal storage disorders
EA201490201A1 (ru) Выявление экспрессии гена prame при раковом заболевании
BRPI0811429A2 (pt) método para a detecção da atividade in vivo de neurotripsina, uso do método e uso do fragmento c-terminal de 22-kda de agrina como biomarcador no diagnóstico e monitoramento de distúrbios relacionados à neurotripsina
AR078101A1 (es) Metodos para diagnosticar la diabetes y determinar la eficacia de tratamientos
BR112018070970A2 (pt) método para diagnóstico de fibrose cística
PT2807486T (pt) Método para a previsão in vitro, numa amostra sanguínea, da probabilidade de um paciente desenvolver dengue grave
ES2637390T3 (es) Tratamiento de afecciones respiratorias
BR112018076005A2 (pt) anticorpo monoclonal isolado, método para medir o nível de gama-glutamil-l-epsilon-lisina (ggel), método ex vivo para o monitoramento de apoptose, uso de um anticorpo monoclonal específico para gama-glutamil-l-epsilon-lisina (ggel), métodos para monitorar a eficácia de um tratamento indutor de apoptose, método de tratamento de uma doença associada a apoptose desregulada, kit para o monitoramento de apoptose, método de tratamento de sepse e dispositivo de imunoensaio de fluxo lateral
PL422611A1 (pl) Sposób wykrywania uszkodzenia nerek pojawiającego się u chorych z cukrzycą
UA62320U (ru) Способ диагностики состояния микроциркуляции крови в норме и патологии

Legal Events

Date Code Title Description
FD Application declared void or lapsed